Soft Tissue Engineering - 03/08/17
Résumé |
There is a recognized need to reconstruct and restore complex craniomaxillofacial soft tissues. The objective of this article is to focus on the role that tissue engineering/regenerative medicine can play in addressing various barriers (vascularity, tissue bulk, volitional control, and esthetics) and impediments (timing, regional applicability/dissemination, and regulation by the US Food and Drug Administration) to optimal tissue reconstruction of complex soft tissue structures. We will use the lips as an example to illustrate our points.
Le texte complet de cet article est disponible en PDF.Keywords : Soft tissue engineering, Craniomaxillofacial surgery, Oral and maxillofacial surgery, Head and neck reconstruction, Composite flap, Prelaminated, Lip reconstruction, Oral mucosa
Plan
| Disclosure Statement: Drs R.Y. Kim or S.S. Bae, do not have any relevant consultancies, stock ownership or other equity interests, or patent licensing arrangements; Dr S.E. Feinberg is a founding member and chair of the CMF advisory board of Tissue Regeneration Systems. The dermal equivalent used in our studies was obtained gratis from LifeCell Corporation, a subsidiary of Acelity. |
|
| Funding: NIH (DE 13417; DE 15784; DE 19431). |
Vol 29 - N° 1
P. 89-104 - février 2017 Retour au numéro
Article précédent
- Maxillofacial Defects and the Use of Growth Factors
- Alan S. Herford, Meagan Miller, Fabrizio Signorino
- New Frontiers in Biomaterials
- R. Gilbert Triplett, Oksana Budinskaya
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?